Quick Answer
MapLight Therapeutics, Inc. reported Earnings Per Share Diluted of $18.56 (loss) per share for the year ending 2025.
- MapLight Therapeutics, Inc. showed an increase of +82.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from MapLight Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $18.56 (loss) per share | Fiscal year 2024: $105.38 (loss) per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: